Adverse Event Reporting
| VAERS ID | 2089063 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | FD9234 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-06-24 |
| Onset | 2021-09-25 |
| Condition | Hospitalized Died |
Symptoms
- Confusional state
- Headache
- Dizziness
- Anxiety
- Dysphonia
- Lung neoplasm malignant
- Metastases to central nervous system
Current Illness
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Write-up
Lung tumor, brain metastases; headache; dizziness; anxiety; hoarseness; confusion; Lung tumor, brain metastases; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from a regulatory authority.
Regulatory number: DE-PEI-CADR2022261370.
Other Case identifier(s): DE-CADRPEI-2022261370, DE-PEI-202200057934.
A 67 year-old female patient received bnt162b2 (COMIRNATY), administration date 24Jun2021 (Lot number: FD9234) as dose 2, 0.
3 ml single for covid-19 immunisation.
The patient's relevant medical history and concomitant medications were not reported.
Vaccination history included: Comirnaty (dose 1 (batch unknown, 0.
3 ml)), administration date: 20May2021, for COVID-19 immunisation.
The following information was reported: LUNG NEOPLASM MALIGNANT (death) with onset 25Sep2021, outcome "fatal", METASTASES TO CENTRAL NERVOUS SYSTEM (hospitalization), outcome "recovering" and all described as "Lung tumor, brain metastases"; HEADACHE (non-serious), outcome "unknown", described as "headache"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; ANXIETY (non-serious), outcome "unknown", described as "anxiety"; DYSPHONIA (non-serious), outcome "unknown", described as "hoarseness"; CONFUSIONAL STATE (non-serious), outcome "unknown", described as "confusion".
The patient date of death was 25Sep2021.
The reported cause of death was lung neoplasm malignant.
It was not reported if an autopsy was performed.
The health authority assessed the drug relatedness as D.
Unclassifiable (Source of assessment: RA, Result of Assessment: D.
Unclassifiable).
Sender Comment: Do you or the person concerned have any known allergies? If yes, which? No / headache, dizziness, anxiety, hoarseness, confusion.
Metastases grew at an extreme rate and became extremely large.
From diagnosis to death 7 weeks.
; Reported Cause(s) of Death: Lung carcinoma